Montpellier University Hospital
Montpellier University Hospital
Montpellier, France5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis | Chemically-Induced Disorders, Digestive System Diseases, Drug-Related Side Effects and Adverse Reactions, bile duct disorder, biliary tract disorder, cholangitis, drug-induced liver injury, hepatitis, liver disorder, poisoning | Recruiting | Not stated | 2026-06-18 | NCT06864481 | |
| Evaluation of the Absence of Intraoperative Bladder Catheterization in Case of Planned Cesarean Section | Cesarean Section; Pregnant Women | Recruiting | Not applicable | 2026-03-12 | NCT06357546 | |
| Plasma Biomarkers of Muscle Metabolism During Exercise to the Assessment of Insulin Resistance in CKD Dialysis Patients | Insulin Resistance, Nutritional and Metabolic Diseases, glucose metabolism disease, hyperinsulinism, metabolic disease | Recruiting | Not applicable | 2024-11-26 | NCT06360302 | |
| IMPELLA, Complications and Tolerance | Embolism and Thrombosis, Hemorrhage, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Cardiogenic, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, thrombotic disease, vascular disorder | Recruiting | Not stated | 2024-10-16 | NCT06644963 | |
| LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMAB | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Phase 3 | 2024-05-17 | NCT05210621 |